网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
含糖透析液在血液透析中应用的利与弊
作者:李琴  郝丽荣 
单位:哈尔滨医科大学第一附属医院 肾内科, 黑龙江 哈尔滨 150001
关键词:含糖透析液 血液透析 血糖 血压 代谢特性 炎症 心率变异性 综述 
分类号:R459.5
出版年·卷·期(页码):2018·46·第五期(586-589)
摘要:

目前含糖透析液的应用逐渐增多,含糖透析液的使用可减少维持性血液透析患者发生低血糖的风险,降低血压,提供更多的能量以及增加高频心率变异性,从而产生更好的心血管预后,但同时也可能增加氧化应激,诱发炎症状态,因此其使用尚存争议。本文作者从含糖透析液对维持性血液透析患者的血糖、血压、代谢特性、炎症及心率变异性等方面的影响作一综述。

参考文献:

[1] BURMEISTER J E,SCAPINI A,da ROSA MILTERSTEINER D,et al.Glucose added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis[J].Nephrol Dial Transplant,2007,22(4):1184-1189.
[2] BERGSTRÖM J,ASABA H,FVRST P,et al.Dialysis,ultrafiltration,and blood pressure.1976[J].Blood Purifi,2006,24(2):226-231.
[3] SHARMA R,ROSNER M H.Glucose in the dialysate:historical perspective and possible implications[J].Hemodial Int,2008,12(2):221-226.
[4] ARSOV S,TRAJCESKA L,van OEVEREN W,et al.The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients[J].Eur J Clin Nutr,2015, 69(3):309-313.
[5] ABE M,KALANTAR-ZADEH K.Haemodialysis-induced hypoglycaemia and glycaemic disarrays[J].Nat Rev Nephrol,2015,11(5):302-313.
[6] RAIMANN J G,KRUSE A,THIJSSEN S,et al.Metabolic effects of dialyzate glucose in chronic hemodialysis:results from a prospective, randomized crossover trial[J].Nephrol Dial Transplant, 2012,27(4):1559-1568.
[7] JACKSON M A,HOLLAND M R,NICHOLAS J,et al.Hemodialysis-induce hypoglycemia in diabetic patients[J].Clin Nephrol,2000,54(1):30-34.
[8] SIMIC-OGRIZOVIC S,BACKUS G,MAYER A,et al.The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients[J].Int J Artif Organs,2001,24(12):863-869.
[9] TAKAHASHI A,KUBOTA T,SHIBAHARA N,et al.The mechanism of hypoglycemia caused by hemodialysis[J].Clin Nephrol,2004,62(5):362-368.
[10] SANGILL M,PEDERSEN E B.The effect of glucose added to the dialysis fluid on blood pressure, blood glucose, and quality of life in hemodialysis patients:a placebo-controlled crossover study[J].Am J Kidney Dis,2006,47(4):636-643.
[11] CUI L,MENG Y,XU D,et al.Analysis of the metabolic properties of maintenance hemodialysis patients with glucose-added dialysis based on high performance liquid chromatography quadrupole time-of-flight mass spectrometry[J].Ther Clin Risk Manag,2013,9:417-425.
[12] LUO X,WU J,JING S,et al. Hyperglycemic stress and carbon stress in diabetic glucotoxicity[J].Aging Dis,2016,7(1):90-110.
[13] RAMSAUER B,ENGELS G E,GRAAFF R,et al.Skin-and plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate[J].BMC Nephrol,2017,18(1):5.
[14] CHU Y W,LIN H M,WANG J J,et al.Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis:a national cohort study[J].PLoS One,2017, 12(3):e0174601.
[15] YAKUBOVICH N,GERSTEIN H C.Serious cardiovascular outcomes in diabetes:the role of hypoglycemia[J].Circulation,2011,123(3):342-348.
[16] ZOUNGAS S,PATEL A,CHALMERS J,et al.Severe hypoglycemia and risks of vascular events and death[J].N Engl J Med,2010,363(15):1410-1418.
[17] GOTO A, ARAH O A, GOTO M, et al. Severe hypoglycaemia and cardiovascular disease:systematic review and meta-analysis with bias analysis[J].BMJ,2013,347(4):f4533.
[18] ORIGIN Trial Investigators, MELLBIN L G, RYDÉN L,et al.Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial[J].Eur Heart J,2013,34(40):3137-3144.
[19] PITSILLIDES A N,ANDERSON S M,KOVATCHEV B.Hypoglycemia risk and glucose variability indices derived from routine self-Monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counter regulation[J].Diabetes Technol Ther,2011,13(1):11-17.
[20] CHERIAN A K,BRISKI K P.A2 noradrenergic nerve cell metabolic transducer and nutrient transporter adaptation to hypoglycemia:impact of estrogen[J].J Neurosci Res,2012, 90(7):1347-1358.
[21] ei YOUSSEF J. In control of type 1 diabetes, despite hypoglycaemia unawareness[J].Lancet Diabetes Endocrinol,2016,4(11):874-875.
[22] SIMIC-OGRIZOVIC S,BACKUS G,MAYER A,et al.The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients[J].Int J Artif Organs,2001,24(12):863-869.
[23] BURMEISTER J E,CAMPOS J F,MILTERSTEINER D R.Effect of different levels of glucose in the dialysate on the risk of hypoglycaemia during hemodialysis in diabetic patients[J].J Bras Nefrol, 2012,34(4):323-327.
[24] DREYER G,GONANI A,LUYCKX V.Hemodialysis[J].N Engl J Med,2011,364(6):584-585.
[25] NAKAO T,INABA M,ABE M,et al.Best practice for diabetic patients on hemodialysis 2012[J].Ther Apher Dial,2015,19(Suppl 1):40-66.
[26] LIU Y,XIAO X,QIN D P,et al.Comparison of intradialytic parenteral nutrition with glucose or amino acid mixtures in maintenance hemodialysis patients[J].Nutrients,2016,8(6):220.
[27] PICONI L,QUAGLIARO L,DA ROS R.Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture:the role of poly (ADP-ribose) polymerase[J].J Thromb Haemost,2004,2(8):1453-1459.
[28] CUI L,MENG Y,XU D,et al.Analysis of the metabolic properties of maintenance hemodialysis patients with glucose-added dialysis based on high performance liquid chromatography quadrupole time-of-flight mass spectrometry[J].Ther Clin Risk Manag,2013,9:417-425.
[29] WILSON C L,MAIDMENT N T,SHOMER M H,et al.Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic kainate rat model of hippocampal epilepsy[J].Epilepsy Res,1996,26(1):245-254.
[30] SCHERMA M,MEDALIE J,FRATTA W,et al.The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition[J].Neuropharmacology,2008,54(1):129-140.
[31] BURSTEIN S H,ROSSETTI R G,YAGEN B,et al.Oxidative metabolism of anandamide[J].Prostag Oth Lipid M,2000,61(1-2):29-41.
[32] WILEY J L,RAZDAN R K,MARTIN B R.Evaluation of the role of the arachi-donic acid cascade in anandamide's in vivo effects in mice[J].Life Sci,2006,80(1):24-35.
[33] OLSZEWSKA M,BOBER J,WIATROW J,et al.The impact of hemodialysis on erythrocyte membrane cytoskeleton proteins[J].Postepy Hig Med Dosw,2015,69:165-175.
[34] SAENGER A K,LAHA T J,EDENFIELE M J,et al.Quantification of urinary 8-iso-PGF2α using liquid chromatography-tandem mass spec-trometry and association with elevated troponin levels[J].Clin Biochem,2007,40(16-17):1297-1304.
[35] KAYSEN G A,EISERICH J P.Characteristics and effects of inflammation in end-stage renal disease[J].Semin Dial,2003,16(6):438-446.
[36] KAYSEN G A.The microinflammatory state in uremia:causes and potential consequences[J].J Am Soc Nephrol,2001,12(7):1549-1557.
[37] STENVINKEL P,KETTELER M,JOHNSON R J,et al.IL-10, IL-6 and TNF-alpha:central factors in the altered cytokine network of uremia-the good, the bad, and the ugly[J].Kidney Int,2005,67(4):1216-1233.
[38] VLASSARA H,PALACE M R.Diabetes and advanced glycation endproducts[J].J Intern Med,2002,251(2):87-101.
[39] 沈潇,刘乃丰.可溶性晚期糖基化终产物受体基础与临床研究新进展[J].东南大学学报(医学版), 2013, 32(3):364-369.
[40] de REKENEIRE N,PEILA R,DING J,et al.Diabetes, hyperglycemia,and inflammation in older individuals:the health, aging and body composition study[J].Diabetes Care,2006,29(8):1902-1908.
[41] ATEGBO J M,GRISSA O,YESSOUFOU A,et al.Modulation of adipokines and cytokines in gestational diabetes and macrosomia[J].J Clin Endocrinol Metab,2006,91(10):4137-4143.
[42] ESPOSITO K,NAPPO F,MARFELLA R,et al.Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans:role of oxidative stress[J].Circulation,2002,106(16):2067-2072.
[43] WASMUTH H E,KUNZ D,GRAF J,et al.Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-α[J].Crit Care Med,2004,32(5):1109-1114.
[44] FERRARIO M,RAIMANN J G,THIJSSEN S,et al.Effects of dialysate glucose concentration on heart rate variability in chronic hemodialysis patients:results of a prospective randomized trial[J].Kidney Blood Press Res,2011,34(5):334-343.
[45] la ROVERE M T,PINNA G D,MAESTRI R,et al.Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients[J].Circulation,2003,107(4):565-570.
[46] CHAN C T.Heart rate variability in patients with end-stage renal disease:an emerging predictive tool for sudden cardiac death[J].Nephrol Dial Transplant,2008,23(10):3061-3062.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 747232 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541